BackOrion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War) Overview

Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War) Operating Income

Track Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War)'s operating income ($-900K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly Operating Income

$-203523.00
↓ 18.63% YoY

As of Dec 31, 2022

Annual Operating Income (TTM)

$-899674.00
↑ 43.21% YoY

Trailing 12 months ending Dec 31, 2022

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin

Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War) (ORIAU) FAQ

As of the most recent data (December 2022), ORIAU shows a operating income of $-900K. That compares with $-630K in the prior-year period — down 43.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ORIAU's operating income is now $-900K (was $-630K) — a 43.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War) is outperforming or lagging.

Tracking ORIAU's operating income over time shows whether Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War) is scaling, shrinking, or reshaping that part of the business. The current reading is $-900K That compares with $-630K in the prior-year period — down 43.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-900K) with ownership activity and broader fundamentals.